Literature DB >> 10756192

MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.

N K Kaludov1, A P Wolffe.   

Abstract

The pathways for selective transcriptional repression of methylated DNA templates by the methyl-CpG-binding protein MeCP2 have been investigated using a purified in vitro transcription system that does not assemble chromatin. MeCP2 selectively inhibits transcription complex assembly on methylated DNA but does not destabilize a pre-assembled transcription complex. MeCP2 functions to repress transcription at a distance of >500 bp from the transcription start site. The transcription repression domain (TRD) of MeCP2 will repress transcription in vitro when fused to a heterologous Gal4 DNA-binding domain. The TRD associates with TFIIB. Exogenous TFIIB does not relieve transcriptional repression established by either intact MeCP2 or a Gal4-TRD fusion protein under these in vitro conditions, nor does the addition of histone deacetylase inhibitors. We find that the transcriptional repression established by both MeCP2 and the Gal4-TRD fusion protein in vitro also correlates with selective assembly of large nucleoprotein complexes. The formation of such complexes reflects a local concentration of DNA-bound transcriptional repressor that may stabilize a state of repression even in the presence of exogenous transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756192      PMCID: PMC103274          DOI: 10.1093/nar/28.9.1921

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

Authors:  P L Jones; G J Veenstra; P A Wade; D Vermaak; S U Kass; N Landsberger; J Strouboulis; A P Wolffe
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

Review 2.  Gene silencing by methyl-CpG-binding proteins.

Authors:  X Nan; S Cross; A Bird
Journal:  Novartis Found Symp       Date:  1998

3.  Replication-coupled chromatin assembly is required for the repression of basal transcription in vivo.

Authors:  G Almouzni; A P Wolffe
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

4.  DNA methylation specifies chromosomal localization of MeCP2.

Authors:  X Nan; P Tate; E Li; A Bird
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

5.  Co-operative binding of the globular domain of histone H5 to DNA.

Authors:  P H Draves; P T Lowary; J Widom
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

6.  The solution structure of the domain from MeCP2 that binds to methylated DNA.

Authors:  R I Wakefield; B O Smith; X Nan; A Free; A Soteriou; D Uhrin; A P Bird; P N Barlow
Journal:  J Mol Biol       Date:  1999-09-03       Impact factor: 5.469

7.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.

Authors:  G E Muscat; L J Burke; M Downes
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

9.  Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.

Authors:  B Coffee; F Zhang; S T Warren; D Reines
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

10.  Role of chromatin and Xenopus laevis heat shock transcription factor in regulation of transcription from the X. laevis hsp70 promoter in vivo.

Authors:  N Landsberger; A P Wolffe
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  40 in total

1.  Functional consequences of Rett syndrome mutations on human MeCP2.

Authors:  T M Yusufzai; A P Wolffe
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.

Authors:  M C Lorincz; D Schübeler; M Groudine
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 3.  Above and within the genome: epigenetics past and present.

Authors:  F D Urnov; A P Wolffe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

4.  Methylation-dependent silencing at the H19 imprinting control region by MeCP2.

Authors:  Robert A Drewell; Carolyn J Goddard; Jean O Thomas; M Azim Surani
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

Review 5.  The marks, mechanisms and memory of epigenetic states in mammals.

Authors:  V K Rakyan; J Preis; H D Morgan; E Whitelaw
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis.

Authors:  Ozren Bogdanovic; Steven W Long; Simon J van Heeringen; Arie B Brinkman; Jose Luis Gómez-Skarmeta; Hendrik G Stunnenberg; Peter L Jones; Gert Jan C Veenstra
Journal:  Genome Res       Date:  2011-06-02       Impact factor: 9.043

Review 7.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

8.  DNA methylation has a local effect on transcription and histone acetylation.

Authors:  Ryan A Irvine; Iping G Lin; Chih-Lin Hsieh
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 9.  Basic concepts of epigenetics: impact of environmental signals on gene expression.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

10.  DNA methylation dictates histone H3K4 methylation.

Authors:  Cindy Yen Okitsu; Chih-Lin Hsieh
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.